Publication | Open Access
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
86
Citations
24
References
2021
Year
MX2 is a potent indicator for sunitinib resistance and a therapeutic target in ccRCC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1